Claudia Fabrizio

Taranto, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Optimizing target inactivation to treat multidrug-resistant Escherichia coli with NDM and PBP3 mutations: "going the extra mile".

Optimizing target inactivation to treat multidrug-resistant Escherichia coli with NDM and PBP3 mutations: "going the extra mile".

Journal: Antimicrobial agents and chemotherapy

Published: February 20, 2026

Chances/Challenges of the Role of New Beta-lactamase Inhibitors Against the Growing Threat of NDM-producing Escherichia coli With Penicillin-binding Protein 3 Mutations.

Chances/Challenges of the Role of New Beta-lactamase Inhibitors Against the Growing Threat of NDM-producing Escherichia coli With Penicillin-binding Protein 3 Mutations.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: August 23, 2024

Cidofovir for treating complicated monkeypox in a man with acquired immune deficiency syndrome.

Cidofovir for treating complicated monkeypox in a man with acquired immune deficiency syndrome.

Journal: Infection

Published: August 25, 2022

Monkeypox in a 71-year-old woman.

Monkeypox in a 71-year-old woman.

Journal: Journal of medical virology

Published: July 01, 2022

Peculiar clinical presentation of COVID-19 and predictors of mortality in the elderly: A multicentre retrospective cohort study.

Peculiar clinical presentation of COVID-19 and predictors of mortality in the elderly: A multicentre retrospective cohort study.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: December 26, 2020

COVID-19-associated pulmonary aspergillosis: adding insult to injury.

COVID-19-associated pulmonary aspergillosis: adding insult to injury.

Journal: The Lancet. Microbe

Published: August 25, 2020

Pharmacogenomics and Pharmacogenetics: In Silico Prediction of Drug Effects in Treatments for Novel Coronavirus SARS-CoV2 Disease.

Pharmacogenomics and Pharmacogenetics: In Silico Prediction of Drug Effects in Treatments for Novel Coronavirus SARS-CoV2 Disease.

Journal: Pharmacogenomics and personalized medicine

Published: July 12, 2020

Pancreatic injury in the course of coronavirus disease 2019: A not-so-rare occurrence.

Pancreatic injury in the course of coronavirus disease 2019: A not-so-rare occurrence.

Journal: Journal of medical virology

Published: May 25, 2020

Short-term outcomes in individuals aged 75 or older with severe coronavirus disease (COVID-19): First observations from an infectious diseases unit in Southern Italy.

Short-term outcomes in individuals aged 75 or older with severe coronavirus disease (COVID-19): First observations from an infectious diseases unit in Southern Italy.

Journal: The Journal of infection

Published: May 05, 2020

Gp120 substitutions at positions associated with resistance to fostemsavir in treatment-naive HIV-1-positive individuals.

Gp120 substitutions at positions associated with resistance to fostemsavir in treatment-naive HIV-1-positive individuals.

Journal: The Journal of antimicrobial chemotherapy

Published: October 06, 2019

Variability OF HIV-1 V2 env domain for integrin binding: Clinical correlates.

Variability OF HIV-1 V2 env domain for integrin binding: Clinical correlates.

Journal: Virology

Published: May 20, 2019

HIV-1 coreceptor tropism: A syllogistic connection with The Veterans Aging Cohort Study Index and the CD4/CD8 ratio.

HIV-1 coreceptor tropism: A syllogistic connection with The Veterans Aging Cohort Study Index and the CD4/CD8 ratio.

Journal: PloS one

Published: November 16, 2018

Showing 1-12 of 26

Last Updated: 09/26/2026